Locoid Lipocreme is used in the symptomatic management of various inflammatory skin conditions. Its therapeutic use is relevant for easing pronounced symptoms in corticosteroid-responsive dermatoses.

---

Therapeutic Scope and Symptom Relief

This medication is commonly used across conditions characterized by periods of heightened symptoms, relevant in clinical settings where supportive symptom management is appropriate. It is used for managing symptom groups that create noticeable functional strain, including persistent pruritus (intense itching), visible redness (erythema), and localized swelling (edema). It is relevant in addressing inflammatory dermatoses such as various forms of eczema, including atopic and contact dermatitis, and localized, non-weeping plaques of psoriasis.

“It provides support that helps ease the overall symptom burden and contributes to improved day-to-day comfort.”

Clinical Scenarios and Patient Benefit

The Lipocreme formulation is generally considered relevant for conditions that present with dryness and thickening, such as chronic lesions. It supports patients during episodes of heightened discomfort by helping to manage symptoms that become more disruptive during flare-ups. This supports general well-being during symptomatic phases and may assist with maintaining functional stability in areas marked by scaling.

Quick Fact: Relief for Inflammation
Symptom Focus	Intense Itching, Redness, and Swelling
Condition Context	Moderately severe eczema and localized psoriasis
Patient Benefit	Contributes to improved comfort during symptomatic periods

Regulatory References

1. National Institutes of Health (NIH) DailyMed

Locoid Lipocreme is formally contraindicated and must not be used by patients with a known hypersensitivity to Hydrocortisone Butyrate or any of its components. Use is strictly excluded in the presence of specific untreated skin infections, including viral (such as Herpes Simplex), fungal, yeast, or tubercular lesions, as defined in regulatory labeling. The medicine is also contraindicated for skin conditions such as rosacea, acne vulgaris, peri-oral dermatitis, and ulcerous skin lesions.

Age-Related Eligibility

The medicine is approved for use in adults and older adults. For pediatric patients, use is established for those 3 months of age and older. Use in children requires extreme caution due to the higher risk of systemic absorption, and treatment must be limited to short durations. Safety and effectiveness are not established for infants under 3 months of age.

Conditional and Restricted Use

During pregnancy, use is restricted to cases where the potential benefit justifies the potential risk to the fetus (FDA Category C). Nursing mothers should use the medicine with caution, limiting application to the smallest area possible. Application to the eyelids must be avoided due to the risk of glaucoma.

Interactions with other medicines and products

Official regulatory information for Locoid Lipocreme (Hydrocortisone Butyrate) focuses primarily on the risks associated with cumulative systemic exposure rather than specific metabolic drug-drug interactions.

---

Pharmacodynamic Interaction Risk

The most significant interaction documented in regulatory sources is the pharmacodynamic additive effect that can occur upon co-administration with other corticosteroid-containing products, whether topical or systemic. Using multiple corticosteroid products simultaneously increases the total systemic glucocorticoid exposure, posing a regulatory-cited risk of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression.

Exposure-Modifying Constraints

While no specific drug-drug metabolic interactions are listed in the official labeling, restrictions are placed on administration methods that are known to alter exposure. The use of occlusive dressings or application in the diaper area is officially cited as augmenting systemic absorption. These procedural constraints are identified as increasing the potential for systemic exposure to the active ingredient.

Population-Specific Considerations

Official documents indicate that certain populations have an increased susceptibility to interaction-related systemic effects. Pediatric patients are identified as having a heightened risk of systemic toxicity due to a greater surface area-to-body mass ratio. Similarly, patients with hepatic impairment are noted as being at an increased risk of elevated systemic exposure.

How Locoid Lipocreme Works: Mechanism

Targeting Cellular Signaling via the Glucocorticoid Receptor

The cream's active ingredient is a Glucocorticoid Receptor agonist, meaning it binds to a specific receptor inside skin cells. This molecular interaction is the initiating step that allows the drug to alter gene activity, which is the core mechanism used to modulate the transcription of specific genes.

---

Suppressing Key Inflammatory Messengers and Enzymes

By modifying gene expression, the drug's mechanism leads to the inhibition of pro-inflammatory mediators like prostaglandins and leukotrienes by blocking the action of enzymes like phospholipase A2. This action reduces the generation of chemical signals that contribute to heightened physiological response.

---

Causing Local Vascular and Cellular Dampening

The cascade of effects includes direct vasoconstriction—the narrowing of small blood vessels near the application site—and the limitation of immune cell migration into the tissue. This leads to the physiological consequences of diminished vasodilation and reduced plasma exudation in the application area.

How to Use Locoid Lipocreme: Official Administration Guidelines

Locoid Lipocreme (Hydrocortisone Butyrate 0.1%) is a topical corticosteroid administered exclusively via the cutaneous route for external application; it is strictly not for oral, ophthalmic, or intravaginal use.

Standard Dosing and Frequency

The standard protocol requires applying a thin layer to the affected skin area, which should be rubbed in gently. The frequency of application is typically defined by regional guidelines and the specific condition. Some regimens call for two or three times daily application, while other guidelines prescribe once or twice daily use. Treatment should be discontinued once control of the condition is achieved.

Procedural Constraints and Duration

Constraint Area	Official Instruction
Application Amount	A thin layer must be applied; quantity should not exceed the required amount.
Duration Principle	Use should be short-term; continuous application has generally not been established beyond 4 weeks in adults.
Restricted Areas	Do not use on the face, underarms, or groin areas unless specifically directed by a healthcare professional.
Occlusion	The cream is generally not to be used with occlusive dressings (e.g., bandages) as this can alter absorption, though it may be prescribed for resistant lesions.

Pediatric Use

For pediatric patients (3 months of age and older), the application is typically two times daily. For infants (below 12 months), courses of treatment are often limited to a maximum of seven days to mitigate potential systemic exposure, and the cream must be avoided in the diaper area.

Recent Clinical Evidence

Locoid Lipocreme (hydrocortisone butyrate 0.1%) is a topical corticosteroid formulation. The evidence supporting its use for various skin conditions originates primarily from randomized, controlled clinical trials.

Core Efficacy and Study Design

The formulation was studied in trials involving patients with corticosteroid-responsive dermatoses and mild to moderate atopic dermatitis. These studies aimed to evaluate the product’s effect on inflammatory and pruritic (itchy) symptoms. Key design elements included:

• Placebo-Controlled Trials: The main studies compared the application of Locoid Lipocreme to a vehicle (the cream base without the active ingredient) to establish the therapeutic contribution of hydrocortisone butyrate.
• Target Populations: Research included both adults and pediatric patients (specifically those 3 months of age and older).

Comparison and Formulation

Clinical trials have evaluated the Lipocreme formulation against other dosage forms of hydrocortisone butyrate, such as the standard cream. These assessments focused on the vasoconstrictor assay, which is an indicator of topical steroid potency and percutaneous absorption. Findings suggested that the Lipocreme formulation exhibited a greater vasoconstrictive effect compared to the standard cream formulation, indicating enhanced delivery of the active ingredient through the skin.

Long-Term Administration and Safety

Studies established that the efficacy and safety of Locoid Lipocreme were not established beyond 4 weeks of use. Specific areas of research related to duration included:

• HPA Axis Suppression: Evaluations were conducted to monitor the potential for reversible suppression of the hypothalamic-pituitary-adrenal (HPA) axis, particularly when the product was applied to large surface areas or used under occlusion.
• Pediatric Risk: Studies noted that pediatric patients may be more susceptible to systemic absorption due to their larger skin-surface-to-body-mass ratios, leading to specific safety monitoring within this group.

Common questions about Locoid Lipocreme (FAQ)

---

Q: What is Locoid Lipocreme used for?

Locoid Lipocreme (hydrocortisone buteprate) is a topical corticosteroid formulation. It is generally indicated for the relief of the inflammatory and pruritic (itching) manifestations of corticosteroid-responsive dermatoses. This may include conditions like eczema and dermatitis where inflammation is present.

---

Q: Is Locoid Lipocreme the same as over-the-counter hydrocortisone?

While Locoid Lipocreme contains a hydrocortisone derivative, hydrocortisone buteprate, it is generally considered a more potent formulation than standard over-the-counter hydrocortisone products. Because of its strength, it is typically a prescription-only medication and should be used only as directed by a healthcare professional.

---

Q: How long does it usually take for Locoid Lipocreme to work?

The time it takes to observe an effect can vary greatly among individuals and depends on the specific skin condition and severity. Some individuals may notice improvements within a few days, while others may require longer periods of treatment. It is important to continue treatment only for the duration specified by the prescriber.

---

Q: What should I do if I miss an application of the cream?

If an application is missed, it is generally advised to apply the cream as soon as you remember, unless it is nearly time for the next scheduled application. In that case, skip the missed application and continue with the regular schedule. Do not apply a double amount to make up for a missed application. Always follow the specific instructions provided by the prescribing physician.

---

Q: Can Locoid Lipocreme be used on the face or in skin folds?

Applying potent topical corticosteroids to sensitive areas such as the face, groin, or armpits may increase the risk of side effects, including skin thinning (atrophy) or perioral dermatitis. If use in these areas is necessary, it should only be done under the strict guidance and monitoring of a healthcare provider.

Locoid Lipocreme (hydrocortisone butyrate) must be stored and handled according to the official requirements detailed in regulatory labeling.

Storage Conditions and Safety

Requirement	Official Condition
Temperature	Store at Controlled Room Temperature, 15^circ to 30 C (59^circ to 86 F).
Protection	Must be protected from freezing, excessive heat, moisture, and direct light.
Container	Store in the original container and ensure it is closed.
Child Safety	Keep out of the sight and reach of children.

Disposal Instructions

Disposal must adhere to environmental regulations. The medicine must not be disposed of via wastewater or general household rubbish. Patients should consult a healthcare professional or pharmacist for guidance on properly discarding any unused or expired product.